| 摘要 |
Stable, physiologically compatible, injectable solutions comprising, as an active ingredient, an alkali metal salt of canrenoic acid or a mixture of an alkali metal canrenoate and a diuretic, and an aqueous, physiologically compatible alkaline buffer having a low buffer capacity and yielding a pH range of 10.2 to 11.2, e.g., tripotassium phosphate, potassium carbonate or potassium glycinate. |
